Pertussis toxin-induced lymphocytosis enhances anti-tumor immune environments and improves the anti-PD1 treatment response in a squamous cell carcinoma model.
RNA-seq (gene expression) · mouse · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 24 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Pertussis toxin-induced lymphocytosis shifts the tumor microenvironment toward immune activation via CXCL9 signalingCancer immunology, immunotherapy : CII · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE311831_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1370977 and SRA study SRP649775. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 8 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9333037 G1 - Tumor single cell, M#1 G1 - Tumor single cell,…
- GSM9333038 G1 - Tumor single cell, M#2 G1 - Tumor single cell,…
- GSM9333039 G1 - Tumor single cell, M#3 G1 - Tumor single cell,…
- GSM9333040 G1 - Lymph node, M#1 G1 - Lymph node, M#
- GSM9333041 G1 - Lymph node, M#2 G1 - Lymph node, M#
- GSM9333042 G1 - Lymph node, M#3 G1 - Lymph node, M#
- GSM9333043 G2 - Tumor single cell, P toxin-induced, M#1 G2 - Tumor single cell,…
- GSM9333044 G2 - Tumor single cell, P toxin-induced, M#2 G2 - Tumor single cell,…
- GSM9333045 G2 - Tumor single cell, P toxin-induced, M#3 G2 - Tumor single cell,…
- GSM9333046 G2 - Lymph node, P toxin-induced, M#1 G2 - Lymph node, P toxi…
- GSM9333047 G2 - Lymph node, P toxin-induced, M#2 G2 - Lymph node, P toxi…
- GSM9333048 G2 - Lymph node, P toxin-induced, M#3 G2 - Lymph node, P toxi…
- GSM9333049 G5 - Tumor single cell, M#1 G5 - Tumor single cell,…
- GSM9333050 G5 - Tumor single cell, M#2 G5 - Tumor single cell,…
- GSM9333051 G5 - Tumor single cell, M#3 G5 - Tumor single cell,…
- GSM9333052 G5 - Lymph node, M#1 G5 - Lymph node, M#
- GSM9333053 G5 - Lymph node, M#2 G5 - Lymph node, M#
- GSM9333054 G5 - Lymph node, M#3 G5 - Lymph node, M#
- GSM9333055 G6 - Tumor single cell, P toxin-induced, M#1 G6 - Tumor single cell,…
- GSM9333056 G6 - Tumor single cell, P toxin-induced, M#2 G6 - Tumor single cell,…
- GSM9333057 G6 - Tumor single cell, P toxin-induced, M#3 G6 - Tumor single cell,…
- GSM9333058 G6 - Lymph node, P toxin-induced, M#1 G6 - Lymph node, P toxi…
- GSM9333059 G6 - Lymph node, P toxin-induced, M#2 G6 - Lymph node, P toxi…
- GSM9333060 G6 - Lymph node, P toxin-induced, M#3 G6 - Lymph node, P toxi…
- GSE248513 Combining anti-PD1 and vorinostat improves anti-tumor treatment in IDH-mutant brain tumors 15 samples shares anti-pd1, anti-tumor, treatment
- GSE231357 Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy 14 samples shares anti-pd1, anti-tumor
- GSE231355 Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy [kdSdc1_RNAseq] 12 samples shares anti-pd1, anti-tumor
- GSE254619 Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy (kdSdc1 and mutant) 10 samples shares anti-pd1, anti-tumor
- GSE321667 Evaluation of potential immune-related adverse events in mouse lung tissues after anti-PD1 or anti-PD1 nanocapsule treatment 9 samples shares anti-pd1, treatment
- GSE262545 Iron boosts anti-tumor type 1 T-cell responses and anti-PD1 immunotherapy 8 samples shares anti-pd1, anti-tumor
- GSE285342 DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden 7 samples shares anti-pd1, enhances
- GSE268555 DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden 4 samples shares anti-pd1, enhances
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.